Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Yu

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
International Journal of Antimicrobial Agents|January 12, 2021
Evaluating the emergence of nonsusceptibility among Pseudomonas aeruginosa respiratory isolates from a phase-3 clinical trial for treatment of nosocomial pneumonia (ASPECT-NP)Matthew G Johnson, Christopher Bruno, Mariana Castanheira, et al.
JTO Clinical and Research Reports|November 3, 2022
Quality of Life After Stereotactic Body Radiation Therapy or Surgery for Early-Stage NSCLC: A Systematic ReviewAustin J Iovoli, Brian Yu, Sung Jun Ma, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
Reference-free Structural Variant Detection in Microbiomes via Long-read Coassembly GraphsKristen D Curry, Feiqiao Brian Yu, Summer E Vance, et al.
Critical Care (London, England)|December 2, 2022
Outcomes in participants with failure of initial antibacterial therapy for hospital-acquired/ventilator-associated bacterial pneumonia prior to enrollment in the randomized, controlled phase 3 ASPECT-NP trial of ceftolozane/tazobactam versus meropenemMarin H Kollef, Jean-François Timsit, Ignacio Martin-Loeches, et al.
Cancers|February 15, 2022
Racial/Ethnic Differences and Trends in Pathologic Complete Response Following Neoadjuvant Chemotherapy for Breast CancerSung Jun Ma, Lucas M Serra, Brian Yu, et al.
Circulation. Heart Failure|November 5, 2022
Impact of Patient-Reported Outcome Measurement in Heart Failure Clinic on Clinician Health Status Assessment and Patient Experience: A Substudy of the PRO-HF TrialAlexander T Sandhu, Jimmy Zheng, Neil M Kalwani, et al.
Molecular and Cellular Biology|February 15, 2017
Protein 4.1R Exon 16 3' Splice Site Activation Requires Coordination among TIA1, Pcbp1, and RBM39 during Terminal ErythropoiesisShu-Ching Huang, Henry S Zhang, Brian Yu, et al.
Pediatric Pulmonology|May 19, 2020
Plasma pharmacokinetics of ceftolozane/tazobactam in pediatric patients with cystic fibrosisAntonio C Arrieta, Jocelyn Y Ang, Zufei Zhang, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Path-dependent recovery of the gut microbiome after antibiotics emerges from coupled ecological and evolutionary dynamicsChinmay Lalgudi, Masakazu Kotaka, Eitan Yaffe, et al.
JACC. Cardiooncology|October 10, 2022
Involvement of Rho-Associated Coiled-Coil Containing Kinase (ROCK) in BCR-ABL1 Tyrosine Kinase Inhibitor Cardiovascular ToxicityBrian Yu, Afaf E G Osman, Nikola Sladojevic, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
International Journal of Antimicrobial Agents|January 12, 2021
Evaluating the emergence of nonsusceptibility among Pseudomonas aeruginosa respiratory isolates from a phase-3 clinical trial for treatment of nosocomial pneumonia (ASPECT-NP)Matthew G Johnson, Christopher Bruno, Mariana Castanheira, et al.
JTO Clinical and Research Reports|November 3, 2022
Quality of Life After Stereotactic Body Radiation Therapy or Surgery for Early-Stage NSCLC: A Systematic ReviewAustin J Iovoli, Brian Yu, Sung Jun Ma, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
Reference-free Structural Variant Detection in Microbiomes via Long-read Coassembly GraphsKristen D Curry, Feiqiao Brian Yu, Summer E Vance, et al.
Critical Care (London, England)|December 2, 2022
Outcomes in participants with failure of initial antibacterial therapy for hospital-acquired/ventilator-associated bacterial pneumonia prior to enrollment in the randomized, controlled phase 3 ASPECT-NP trial of ceftolozane/tazobactam versus meropenemMarin H Kollef, Jean-François Timsit, Ignacio Martin-Loeches, et al.
Cancers|February 15, 2022
Racial/Ethnic Differences and Trends in Pathologic Complete Response Following Neoadjuvant Chemotherapy for Breast CancerSung Jun Ma, Lucas M Serra, Brian Yu, et al.
Circulation. Heart Failure|November 5, 2022
Impact of Patient-Reported Outcome Measurement in Heart Failure Clinic on Clinician Health Status Assessment and Patient Experience: A Substudy of the PRO-HF TrialAlexander T Sandhu, Jimmy Zheng, Neil M Kalwani, et al.
Molecular and Cellular Biology|February 15, 2017
Protein 4.1R Exon 16 3' Splice Site Activation Requires Coordination among TIA1, Pcbp1, and RBM39 during Terminal ErythropoiesisShu-Ching Huang, Henry S Zhang, Brian Yu, et al.
Pediatric Pulmonology|May 19, 2020
Plasma pharmacokinetics of ceftolozane/tazobactam in pediatric patients with cystic fibrosisAntonio C Arrieta, Jocelyn Y Ang, Zufei Zhang, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Path-dependent recovery of the gut microbiome after antibiotics emerges from coupled ecological and evolutionary dynamicsChinmay Lalgudi, Masakazu Kotaka, Eitan Yaffe, et al.
JACC. Cardiooncology|October 10, 2022
Involvement of Rho-Associated Coiled-Coil Containing Kinase (ROCK) in BCR-ABL1 Tyrosine Kinase Inhibitor Cardiovascular ToxicityBrian Yu, Afaf E G Osman, Nikola Sladojevic, et al.
Pageof 10